Inside Covid-19: Wits gets second global vaccine trial - this time Novavax; Vitality enhancements for over 65s. Ep 73

In episode 73 of Inside Covid-19 there's a focus on vaccines – first with Wits professor Shabir Madhi whose unit was selected by US drug company Novavax to run a critical 2b trial of its coronavirus vaccine. Courtesy of a $15m donation from the Gates Foundation, Wits will conduct a 2,900 person trial of the Novavax vaccine; it began a similar trial for the promising Oxford University vaccine seven weeks ago. We’ll also hear from our partners at Bloomberg why the civilized world isn’t banking on Russia’s Sputnik V vaccine which was announced last week. Also tonight, Discovery’s Vitality creates fresh incentives to encourage its 65-plus members to adopt lifestyle habits to better prepare them in the fight against Covid-19. - Alec Hogg